Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures

被引:9
|
作者
Antonelli, T.
Tomasini, M. C.
Tattoli, M.
Cassano, T.
Finetti, S.
Mazzoni, E.
Trabace, L.
Carratu, M. R.
Cuomo, V.
Tanganelli, S.
Ferraro, L.
机构
[1] Univ Ferrara, Pharmacol Sect, Dept Clin & Expt Med, I-44100 Ferrara, Italy
[2] Univ Bari, Dept Pharmacol & Human Physiol, Bari, Italy
[3] Univ Foggia, Dept Biomed Sci, Foggia, Italy
[4] Univ Roma La Sapienza, Dept Pharmacol & Gen Physiol, Rome, Italy
关键词
SR141716A; basal and K+-evoked glutamate levels; maternal marijuana exposure;
D O I
10.1016/j.neuint.2006.04.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 (0.5 mg/kg s.c.), alone or in combination with carbon monoxide, on extracellular glutamate levels in primary rat cerebral cortical neuronal cultures, were investigated. Dam weight gain, pregnancy length and litter size at birth were not affected by prenatal treatment with WIN 55,212-2 and carbon monoxide alone or in combination. Basal and K+-evoked extracellular glutamate levels were reduced in cortical cultures from pups born to mothers exposed to WIN 55,212-2 and carbon monoxide alone or in combination compared to cultures from rats born to vehicle-treated mothers. In cultures obtained from rats exposed to vehicle or carbon monoxide alone during gestation, WIN 55,212-2 (0.01-100 nM) increased extracellular glutamate levels, displaying a bell-shaped concentration-response curve. In cultures from rats born to mothers exposed to WIN 55,212-2 alone or in combination with carbon monoxide the WIN 55,212-2 (1 nM)-induced increase in extracellular glutamate levels was lower than that observed in cultures from rats born to vehicle-treated mothers and similar at those observed at 10 and 100 nM concentrations. The selective CB I receptor antagonist SR141716A (10 nM) counteracted the WIN 55,212-2-induced increase in extracellular glutamate levels in cultures exposed to vehicle or carbon monoxide during gestation, but failed to antagonise it in cultures from rats born to mothers exposed to WIN 55,212-2 alone or in combination with carbon monoxide. These findings provide evidence that prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide, alone or in combination, is associated with an impairment in cortical glutamatergic transmission. It could be speculated that such detrimental effects might be involved in the reported deficit in learning and memory associated with prenatal marijuana exposure. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:568 / 576
页数:9
相关论文
共 50 条
  • [1] The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex:: an in vivo and in vitro study
    Ferraro, L
    Tomasini, MC
    Gessa, GL
    Bebe, BW
    Tanganelli, S
    Antonelli, T
    CEREBRAL CORTEX, 2001, 11 (08) : 728 - 733
  • [2] Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex
    Castaldo, Pasqualina
    Magi, Simona
    Gaetani, Silvana
    Cassano, Tommaso
    Ferraro, Luca
    Antonelli, Tiziana
    Amoroso, Salvatore
    Cuomo, Vincenzo
    NEUROPHARMACOLOGY, 2007, 53 (03) : 369 - 378
  • [3] Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate γ-aminobutyric acid levels
    Ferraro, L
    Tomasini, MC
    Cassano, T
    Bebe, BW
    Siniscalchi, A
    O'Connor, WT
    Magee, P
    Tanganelli, S
    Cuomo, V
    Antonelli, T
    JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (02) : 298 - 302
  • [4] Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2
    Nallapaneni, Anuradha
    Liu, Jing
    Karanth, Subramanya
    Pope, Carey
    TOXICOLOGY, 2006, 227 (1-2) : 173 - 183
  • [5] A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats
    Pascual, D
    Goicoechea, C
    Suardíaz, M
    Martín, MI
    PAIN, 2005, 118 (1-2) : 23 - 34
  • [6] The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats
    Schneider, M
    Koch, M
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (01): : 29 - 37
  • [7] Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist
    Bilir, K. A.
    Anli, G.
    Ozkan, E.
    Gunduz, O.
    Ulugol, A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (05) : 553 - 558
  • [8] The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum
    Pintor, A.
    Tebano, M. T.
    Martire, A.
    Grieco, R.
    Galluzzo, M.
    Scattoni, M. L.
    Pezzola, A.
    Coccurello, R.
    Felici, F.
    Cuomo, V.
    Piomelli, D.
    Calamandrei, G.
    Popoli, P.
    NEUROPHARMACOLOGY, 2006, 51 (05) : 1004 - 1012
  • [9] Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test
    Kang, Sinyoung
    Kim, Chi Hyo
    Lee, Heeseung
    Kim, Dong Yeon
    Han, Jong In
    Chung, Rack Kyung
    Lee, Guie Yong
    ANESTHESIA AND ANALGESIA, 2007, 104 (03): : 719 - 725
  • [10] Sex- and age-specific respiratory alterations induced by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 in rats
    Patrone, Luis Gustavo A.
    Ferrari, Gustavo D. D.
    da Silva, Rodrigo Moreira
    Alberici, Luciane C. C.
    Lopes, Norberto Peporine
    Stabile, Angelita M. M.
    Klein, Wilfried
    Bicego, Kenia C.
    Gargaglioni, Luciane H. H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (13) : 1766 - 1789